162648-32-0

Basic information

• Product Name: 4-Piperidinecarboxylicacid,4-methyl-(9CI)
• Synonyms: 4-Piperidinecarboxylicacid,4-methyl-(9CI);4-methyl-4-piperidinecarboxylic acid(SALTDATA: HCl);4-Methyl-4-piperidinecarboxylic acid;4-Methylpiperidine-4-carboxylic acid hydrochloride;4-Methylpiperidine-4-carboxylic acid;4-Methylisonipecotic acid
• CAS NO: 162648-32-0
• Molecular Formula: C7H14ClNO2
• Molecular Weight: 179.64456
• Product Categories: CARBOXYLICACID
• Mol File: 162648-32-0.mol

Chemical Properties

• Boiling Point: 259.5±33.0℃ (760 Torr)
• Flash Point: 110.7±25.4℃
• Appearance: /
• Density: 1.075±0.06 g/cm3 (20 ºC 760 Torr)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 4-Piperidinecarboxylicacid,4-methyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Piperidinecarboxylicacid,4-methyl-(9CI)(162648-32-0)
• EPA Substance Registry System: 4-Piperidinecarboxylicacid,4-methyl-(9CI)(162648-32-0)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36/37/38
• Safety Statements: 26
• HazardClass: IRRITANT
• Hazardous Substances Data: 162648-32-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Piperidinecarboxylic acid, 4-methyl-(9CI) is used as a building block or intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs with specific therapeutic properties.
Used in the Synthesis of DGKα Inhibitors:
4-Methylpiperidine-4-carboxylic Acid Hydrochloride, a derivative of 4-Piperidinecarboxylic acid, 4-methyl-(9CI), is used in the preparation of substituted aminoquinolones. These aminoquinolones act as DGKα (Diacylglycerol Kinase alpha) inhibitors, which play a role in immune activation. By inhibiting DGKα, these compounds can potentially modulate the immune response and be used in the treatment of various immune-related disorders.

Upstream product

• 189321-63-9 1-(tert-butoxycarbonyl)-4-methylpiperidine-4-carboxylic acid 
• 892493-16-2 4-methyl-piperidine-4-carboxylic acid methyl ester 
• 162648-31-9 1-benzoyl-4-methylpiperidine-4-carboxylic acid 
• 189442-87-3 ethyl tert-butyl 4-methylpiperidine-1,4-dicarboxylate 
• 439944-43-1 ethyl 1-methoxycarbonyl-4-piperidinecarboxylate 
• 439944-44-2 ethyl 1-methoxycarbonyl-4-methyl-4-piperidinecarboxylate 

Downstream Products

• 162648-33-1 1,4-dimethylpiperidine-4-carboxylic acid 
• 189321-63-9 1-(tert-butoxycarbonyl)-4-methylpiperidine-4-carboxylic acid 

Relevant articles and documents

PYRAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY

A series of substituted pyrazolo[1,5-a]pyridine derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.

NEW PYRIDINE ANALOGUES

The present invention relates to certain new pyridin analogues of Formula (I) Chemical formula should be inserted here. Please see paper copy Formula (I) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.

NOVEL BENZAMIDINE COMPOUND

A novel compound, or a pharmaceutically acceptable salt thereof, represented by the formula (1) wherein the characters are as defined in the description. Thus, there can be provided an activated blood coagulation factor X inhibitor and a novel anti(blood)

Novel class of potent 4-arylalkyl substituted 3-isoxazolol GABAA antagonists: Synthesis, pharmacology, and molecular modeling

A number of analogues of the low-efficacy partial GABAA agonist 5-(4-piperidyl)-3-isoxazolol (4-PIOL, 5), in which the 4-position of the 3-isoxazolol ring was substituted by different groups, were synthesized and tested as GABAA rece

Hindered esters of rapamycin

A compound of the structure STR1 wherein R and R1 are each, independently, STR2 or hydrogen; R2 and R3 are each, independently, alkyl, arylalkyl, or R2 and R3 may be taken together to form a cycloalky